RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ABU-GHANEM Y
Collezione AOU Novara

Items : 17

Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines Panel. in European urology oncology / Eur Urol Oncol. 2025 Jun;8(3):616-622. doi: 10.1016/j.euo.2025.01.013. Epub 2025 Apr 10.

2025
AOU Novara

Marconi L; Kuusk T; Hora M; Klatte T; Dabestani S; Capitanio U; Abu-Ghanem Y; Campi R; Fernández-Pello S; Albiges L; Bedke J; Powles T; Volpe A; Ljungberg B; Bex A;

Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5. in European urology / Eur Urol. 2023 Mar;83(3):e74-e75. doi: 10.1016/j.eururo.2022.12.001. Epub 2022 Dec 14.

2023
AOU Novara

Capitanio U; Bedke J; Albiges L; Volpe A; Giles RH; Hora M; Marconi L; Klatte T; Abu-Ghanem Y; Dabestani S; Fernández Pello S; Hofmann F; Kuusk T; Campi R; Tahbaz R; Powles T; Ljungberg B; Bex A;

The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma. in European urology / Eur Urol. 2023 Jan;83(1):10-14. doi: 10.1016/j.eururo.2022.10.010. Epub 2022 Oct 27.

2023
AOU Novara

Bedke J; Albiges L; Capitanio U; Giles RH; Hora M; Ljungberg B; Marconi L; Klatte T; Volpe A; Abu-Ghanem Y; Dabestani S; Fernández-Pello S; Hofmann F; Kuusk T; Tahbaz R; Powles T; Bex A;

A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. in European urology / Eur Urol. 2023 Jan;83(1):3-5. doi: 10.1016/j.eururo.2022.09.026. Epub 2022 Oct 15.

2023
AOU Novara

Capitanio U; Bedke J; Albiges L; Volpe A; Giles RH; Hora M; Marconi L; Klatte T; Abu-Ghanem Y; Dabestani S; Fernández Pello S; Hofmann F; Kuusk T; Tahbaz R; Powles T; Ljungberg B; Bex A;

European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist's Point of View. in European urology / Eur Urol. 2023 Feb;83(2):97-100. doi: 10.1016/j.eururo.2022.11.001. Epub 2022 Nov 23.

2023
AOU Novara

Hora M; Albiges L; Bedke J; Campi R; Capitanio U; Giles RH; Ljungberg B; Marconi L; Klatte T; Volpe A; Abu-Ghanem Y; Dabestani S; Fernández-Pello S; Hofmann F; Kuusk T; Tahbaz R; Powles T; Bex A; Trpkov K;

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. in European urology / Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26.

2022
AOU Novara

Ljungberg B; Albiges L; Abu-Ghanem Y; Bedke J; Capitanio U; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Klatte T; Kuusk T; Lam TB; Marconi L; Powles T; Tahbaz R; Volpe A; Bex A;

2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma. in European urology / Eur Urol. 2022 Feb;81(2):134-137. doi: 10.1016/j.eururo.2021.11.022. Epub 2021 Dec 15.

2022
AOU Novara

Bedke J; Albiges L; Capitanio U; Giles RH; Hora M; Lam TB; Ljungberg B; Marconi L; Klatte T; Volpe A; Abu-Ghanem Y; Dabestani S; Fernández-Pello S; Hofmann F; Kuusk T; Tahbaz R; Powles T; Bex A;

Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy? in BJU international / BJU Int. 2021 Sep;128(3):386-394. doi: 10.1111/bju.15415. Epub 2021 Apr 26.

2021
AOU Novara

Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A;

The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care. in European urology / Eur Urol. 2021 Oct;80(4):393-397. doi: 10.1016/j.eururo.2021.04.042. Epub 2021 May 29.

2021
AOU Novara

Bedke J; Albiges L; Capitanio U; Giles RH; Hora M; Lam TB; Ljungberg B; Marconi L; Klatte T; Volpe A; Abu-Ghanem Y; Dabestani S; Pello SF; Hofmann F; Kuusk T; Tahbaz R; Powles T; Bex A;

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma. in European urology / Eur Urol. 2021 Mar;79(3):339-342. doi: 10.1016/j.eururo.2020.12.005. Epub 2020 Dec 24.

2021
AOU Novara

Tahbaz R; Powles T; Kuusk T; Fernández-Pello S; Hofmann F; Dabestani S; Abu-Ghanem Y; Volpe A; Klatte T; Marconi L; Ljungberg B; Lam TB; Hora M; Giles RH; Capitanio U; Bedke J; Albiges L; Bex A;

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium. in European urology oncology / Eur Urol Oncol. 2021 Jun;4(3):473-482. doi: 10.1016/j.euo.2020.09.005. Epub 2020 Oct 24.

2021
AOU Novara

Klatte T; Ljungberg B; Meijer RP; Volpe A; Nisen H; Fernandéz-Pello S; Marconi L; Lam TB; Gudmundsson EO; Stewart GD; Järvinen P; Capitanio U; Beisland C; Powles T; Abu-Ghanem Y; Dabestani S; Bex A;

Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. in European urology oncology / Eur Urol Oncol. 2020 Feb;3(1):57-72. doi: 10.1016/j.euo.2019.04.005. Epub 2019 Jun 4.

2020
AOU Novara

Fernández-Pello S; Hora M; Kuusk T; Tahbaz R; Dabestani S; Abu-Ghanem Y; Albiges L; Giles RH; Hofmann F; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Volpe A; Ljungberg B; Bex A; Bensalah K;

Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel. in European urology oncology / Eur Urol Oncol. 2020 Aug;3(4):433-452. doi: 10.1016/j.euo.2020.02.001. Epub 2020 Mar 31.

2020
AOU Novara

Kuusk T; Marconi L; Kuczyk MA; Hora M; Hofmann F; Dabestani S; Giles RH; Albiges L; Ljungberg B; Bex A; Fernández-Pello S; Abu-Ghanem Y; Merseburger AS; Tahbaz R; Staehler M; Volpe A; Powles T; Lam TB; Bensalah K;

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. in European urology / Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23.

2019
AOU Novara

Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A;

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma. in European urology / Eur Urol. 2019 Aug;76(2):151-156. doi: 10.1016/j.eururo.2019.05.022.

2019
AOU Novara

Albiges L; Powles T; Staehler M; Bensalah K; Giles RH; Hora M; Kuczyk MA; Lam TB; Ljungberg B; Marconi L; Merseburger AS; Volpe A; Abu-Ghanem Y; Dabestani S; Fernández-Pello S; Hofmann F; Kuusk T; Tahbaz R; Bex A;

Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma. in European urology / Eur Urol. 2018 Dec;74(6):805-809. doi: 10.1016/j.eururo.2018.08.008. Epub 2018 Aug 31.

2018
AOU Novara

Bex A; Albiges L; Ljungberg B; Bensalah K; Dabestani S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Fernández-Pello S; Tahbaz R; Abu-Ghanem Y; Staehler M; Volpe A; Powles T;

A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations. in European urology / Eur Urol. 2018 Dec;74(6):849-851. doi: 10.1016/j.eururo.2018.08.029. Epub 2018 Sep 7.

2018
AOU Novara

Bex A; Albiges L; Staehler M; Bensalah K; Giles RH; Dabestani S; Hofmann F; Hora M; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Fernández-Pello S; Tahbaz R; Abu-Ghanem Y; Volpe A; Ljungberg B; Escudier B; Powles T;